Home
/
BIOXYTRAN, INC
/
Financials
/
Quarterly
BIOXYTRAN, INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIOXYTRAN, INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$20.3K
Jul 31, 2018
Q1
2018
Mar 31, 2018
$13.3K
May 15, 2018
Q2
2018
Jun 30, 2017
$39.5K
Jul 31, 2018
Q1
2018
Mar 31, 2017
$7.4K
May 15, 2018
Q2
2017
Jun 30, 2016
$55.6K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$31.5K
May 15, 2017
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$101.1K
Dec 9, 2016
Q2
2016
Jun 30, 2016
$55.6K
Sep 20, 2016
Q1
2016
Mar 31, 2016
$31.5K
Sep 20, 2016
Q3
2016
Sep 30, 2015
$110.8K
Dec 9, 2016
Q2
2016
Jun 30, 2015
$59.4K
Sep 20, 2016
Q1
2016
Mar 31, 2015
$62.5K
Sep 20, 2016
Q3
2015
Sep 30, 2014
$41.5K
Nov 12, 2015
Q2
2015
Jun 30, 2014
$37.8K
Aug 19, 2015
Q1
2015
Mar 31, 2014
$208.4K
May 19, 2015
Q3
2014
Sep 30, 2013
$55.7K
Nov 13, 2014
Q2
2014
Jun 30, 2013
$98.9K
Aug 12, 2014
Q1
2014
Mar 31, 2013
$114.3K
May 14, 2014
Q3
2013
Sep 30, 2012
($9.9K)
Nov 18, 2013
Q2
2012
Jun 30, 2012
$125.7K
Jan 22, 2013
Q1
2013
Mar 31, 2012
$133.4K
May 15, 2013
Q3
2011
Sep 30, 2011
$13.2K
Dec 31, 2012
Q2
2012
Jun 30, 2011
$32.1K
Jan 22, 2013
Q1
2012
Mar 31, 2011
$7.9K
Jan 22, 2013
Q3
2011
Sep 30, 2010
$1.8K
Dec 31, 2012
Q2
2011
Jun 30, 2010
$6.5K
Dec 31, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($282.7K)
Nov 14, 2025
Q3
2025
Jun 30, 2025
$35.4K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$35.4K
Aug 11, 2025
Q3
2025
Mar 31, 2025
($1.35M)
Nov 14, 2025
Q1
2025
Mar 31, 2025
($1.35M)
May 15, 2025
Q2
2025
Mar 31, 2025
($1.35M)
Aug 11, 2025
Q3
2025
Sep 30, 2024
($392.4K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($661.6K)
Aug 11, 2025
Q3
2025
Jun 30, 2024
($661.6K)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($560.5K)
Aug 11, 2025
Q3
2025
Mar 31, 2024
($560.5K)
Nov 14, 2025
Q1
2025
Mar 31, 2024
($560.5K)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.09M)
Oct 29, 2024
Q3
2024
Jun 30, 2023
($1.45M)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($1.45M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($785.1K)
Oct 29, 2024
Q1
2024
Mar 31, 2023
($785.1K)
Apr 19, 2024
Q2
2024
Mar 31, 2023
($785.1K)
Aug 14, 2024
Q3
2023
Sep 30, 2022
($123.6K)
Nov 3, 2023
Q3
2023
Jun 30, 2022
($622.3K)
Nov 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($496.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($224.1K)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($515.1K)
May 15, 2025
Q3
2025
Sep 30, 2024
($346.2K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($609.3K)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($779.2K)
May 15, 2025
Q3
2024
Sep 30, 2023
($985.5K)
Oct 29, 2024
Q2
2024
Jun 30, 2023
($1.06M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($750.2K)
Apr 19, 2024
Q3
2023
Sep 30, 2022
$14.2K
Nov 3, 2023
Q2
2023
Jun 30, 2022
($537.2K)
Jul 31, 2023
Q1
2023
Mar 31, 2022
($819.1K)
May 12, 2023
Q3
2022
Sep 30, 2021
($547.2K)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($1.04M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.69M)
May 23, 2022
Q3
2021
Sep 30, 2020
($114.4K)
Nov 17, 2021
Q2
2021
Jun 30, 2020
($111.9K)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($266.0K)
May 17, 2021
Q3
2020
Sep 30, 2019
($850.3K)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($106.5K)
Aug 7, 2020